AAAAAA

   
Results: 1-18 |
Results: 18
COST OF MIGRAINE MANAGEMENT - A PHARMACOECONOMIC OVERVIEW
Authors: RAPOPORT AM ADELMAN JU
Citation: Am. Rapoport et Ju. Adelman, COST OF MIGRAINE MANAGEMENT - A PHARMACOECONOMIC OVERVIEW, American journal of managed care, 4(4), 1998, pp. 531-545
PHARMACOLOGICAL PREVENTION OF MIGRAINE
Authors: RAPOPORT AM
Citation: Am. Rapoport, PHARMACOLOGICAL PREVENTION OF MIGRAINE, Clinical neuroscience, 5(1), 1998, pp. 55-59
CONSISTENT EFFICACY BETWEEN AND WITHIN PATIENTS TREATED WITH 2.5 AND 5 MG ZOLMITRIPTAN (ZOMIG(TM))
Authors: RAPOPORT AM ADELMAN J
Citation: Am. Rapoport et J. Adelman, CONSISTENT EFFICACY BETWEEN AND WITHIN PATIENTS TREATED WITH 2.5 AND 5 MG ZOLMITRIPTAN (ZOMIG(TM)), Neurology, 50(4), 1998, pp. 5003-5003
LACK OF IMPACT OF GENDER, AGE, AND RENAL-FAILURE ON ZOLMITRIPTAN, AN ACUTE TREATMENT FOR MIGRAINE
Authors: TAYLOR F RAPOPORT AM
Citation: F. Taylor et Am. Rapoport, LACK OF IMPACT OF GENDER, AGE, AND RENAL-FAILURE ON ZOLMITRIPTAN, AN ACUTE TREATMENT FOR MIGRAINE, Neurology, 50(4), 1998, pp. 5005-5005
THE LONG-TERM TOLERABILITY AND EFFICACY OF ORAL ZOLMITRIPTAN (ZOMIG, 311C90) IN THE ACUTE TREATMENT OF MIGRAINE - AN INTERNATIONAL STUDY
Authors: ADELMAN JU BAUMEL B CADY RK BAKER CC COUCH JR DALESSIO DJ DIAMOND S ELKIND AH FOSTER CA GOLDSTEIN J KATZ DA KIRCHNER JR KLAPPER JA KUDROW DB KUNKEL R LANDY SH LICHT JM LINDER SL LODER E MARKLEY HG MATHEW NT MEYER JS NETT R PACKARD RC PERSE T PETERS KS RAMADAN NM RAPOPORT AM ROSING HS SADOWSKY C SAPER JR SHARFMAN MI SILBERSTEIN SD SINGER RP SMITH R SOLOMON G SOLOMON S STARK SR SWANSON JW TAYLOR FR TEPPER SJ TUCHMAN MM VIJAYAN N WALKER J WARD T WARNER JS WENDT JK WINNER P BERAN P BLACK A DONNAN G HERKES G LORD G ZAGAMI A BAUMHACKL U BROUSSALIS T KLINGLER D LADURNER G JACQUY J LOUIS P SCHOENEN J GAWEL MJ HANSEN PE JENSEN K PEDERSEN KK KORSGAARD A LADEMANN A OLESEN J SIMONSEN N SORENSEN PS JENSEN TS TFELTHANSEN P KAASIK AE ZUPPING R FARKKILA M HAANPAA M HAVANKA H HEDMAN C ILMAVIRTA M KINNUNEN E LIUKKONEN J PARTINEN M RAUTAKORPI I REUNANEN M SAKO E SEPPA JM BAREGE M CHAZOT G COLOMBANI JP DUJARDIN M FABRE N GIACOMINO A GERAUD G HENRY P",JOGEIX,"LAPORTE A",LICHTBLAU,"MASSIOU H",MAZINGUEDESAILLY,"MIHOUT B PETIT H VEYRIE M VILAREM H WILMANN JF BECKMANNREINHOLDT A DIENER HC EVERS S GOBEL H KLEPEL H KUHL W LANGOHR HD NEU I PAULUS W PEIKERT A PFAFFENRATH V SCHOLZ E STRAUBE A WITTE OW HARMOUSI S KARAGEORGIOU C MILONAS I GIACOVAZZO M NAPPI G TERBERG JWM SANDERS EACM VANDERZWAN JL EDLAND A ENGELSEN B GRONNING M HALDORSEN T HODNEBO A LARSEN JP DORNZAL T PRUSINSKI A SZCZUDLIK A NAYA MG GRANELL AN LAINEZ JM LEIRA R LIANO H PASCUAL J BOIVIE J DAHLOF C EDVINSSON L HARDEBO JE NILSSON H WALDENLIND E ISLER HR CRAWFORD P DOWSON AJ FINDLEY L GROSS M HAWKES CH JESTICO J ROLAN P STEINER TJ WILKINSON M WAGNER G
Citation: Ju. Adelman et al., THE LONG-TERM TOLERABILITY AND EFFICACY OF ORAL ZOLMITRIPTAN (ZOMIG, 311C90) IN THE ACUTE TREATMENT OF MIGRAINE - AN INTERNATIONAL STUDY, Headache, 38(3), 1998, pp. 173-183
ZOLMITRIPTAN - A VIEWPOINT
Authors: RAPOPORT AM
Citation: Am. Rapoport, ZOLMITRIPTAN - A VIEWPOINT, CNS DRUGS, 7(6), 1997, pp. 479-479
INTRANASAL MEDICATIONS FOR THE TREATMENT OF MIGRAINE AND CLUSTER HEADACHE
Authors: RAPOPORT AM SHEFTELL FD
Citation: Am. Rapoport et Fd. Sheftell, INTRANASAL MEDICATIONS FOR THE TREATMENT OF MIGRAINE AND CLUSTER HEADACHE, CNS DRUGS, 7(1), 1997, pp. 37-46
OPTIMIZING THE DOSE OF ZOLMITRIPTAN (ZOMIG,ASTERISK 311C90) FOR THE ACUTE TREATMENT OF MIGRAINE - A MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE RANGE-FINDING STUDY
Authors: RAPOPORT AM RAMADAN NM ADELMAN JU MATHEW NT ELKIND AH KUDROW DB EARL NL
Citation: Am. Rapoport et al., OPTIMIZING THE DOSE OF ZOLMITRIPTAN (ZOMIG,ASTERISK 311C90) FOR THE ACUTE TREATMENT OF MIGRAINE - A MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE RANGE-FINDING STUDY, Neurology, 49(5), 1997, pp. 1210-1218
CHARACTERISTICS OF MIGRAINE VISUAL AURA
Authors: QUEIROZ LP RAPOPORT AM WEEKS RE SHEFTELL FD SIEGEL SE BASKIN SM
Citation: Lp. Queiroz et al., CHARACTERISTICS OF MIGRAINE VISUAL AURA, Headache, 37(3), 1997, pp. 137-141
ANALGESIC AND ERGOTAMINE REBOUND HEADACHE
Authors: RAPOPORT AM PRINCE PB
Citation: Am. Rapoport et Pb. Prince, ANALGESIC AND ERGOTAMINE REBOUND HEADACHE, Cephalalgia, 16(7), 1996, pp. 461-461
MO AND MA - DISTINCT CLINICAL ENTITIES
Authors: RAPOPORT AM
Citation: Am. Rapoport, MO AND MA - DISTINCT CLINICAL ENTITIES, Cephalalgia, 16(4), 1996, pp. 215-215
EARLY AND TRANSIENT SIDE-EFFECTS OF REPETITIVE INTRAVENOUS DIHYDROERGOTAMINE
Authors: QUEIROZ LP WEEKS RE RAPOPORT AM SHEFTELL FD BASKIN SM SIEGEL SE
Citation: Lp. Queiroz et al., EARLY AND TRANSIENT SIDE-EFFECTS OF REPETITIVE INTRAVENOUS DIHYDROERGOTAMINE, Headache, 36(5), 1996, pp. 291-294
ORAL SUMATRIPTAN IN PREVENTING HEADACHE RECURRENCE AFTER TREATMENT OFMIGRAINE ATTACKS WITH SUBCUTANEOUS SUMATRIPTAN
Authors: RAPOPORT AM VISSER WH CUTLER NR ALDERTON CJ PAULSGROVE LA DAVIS RL FERRARI MD
Citation: Am. Rapoport et al., ORAL SUMATRIPTAN IN PREVENTING HEADACHE RECURRENCE AFTER TREATMENT OFMIGRAINE ATTACKS WITH SUBCUTANEOUS SUMATRIPTAN, Neurology, 45(8), 1995, pp. 1505-1509
INPATIENT HEADACHE TREATMENT - ANALYSIS OF OUTCOME POSTDISCHARGE
Authors: RAPOPORT AM WEEKS RE BASKIN SM SHEFTELL FD
Citation: Am. Rapoport et al., INPATIENT HEADACHE TREATMENT - ANALYSIS OF OUTCOME POSTDISCHARGE, Neurology, 45(4), 1995, pp. 379-379
MIGRAINE PROPHYLAXIS WITH DIVALPROEX
Authors: MATHEW NT SAPER JR SILBERSTEIN SD RANKIN L MARKLEY HG SOLOMON S RAPOPORT AM SILBER CJ DEATON RL
Citation: Nt. Mathew et al., MIGRAINE PROPHYLAXIS WITH DIVALPROEX, Archives of neurology, 52(3), 1995, pp. 281-286
UPDATE ON SEVERE HEADACHE WITH A FOCUS ON MIGRAINE
Authors: RAPOPORT AM
Citation: Am. Rapoport, UPDATE ON SEVERE HEADACHE WITH A FOCUS ON MIGRAINE, Neurology, 44(5), 1994, pp. 5-5
RECURRENT MIGRAINE - COST-EFFECTIVE CARE
Authors: RAPOPORT AM
Citation: Am. Rapoport, RECURRENT MIGRAINE - COST-EFFECTIVE CARE, Neurology, 44(5), 1994, pp. 25-28
SUBCUTANEOUS SUMATRIPTAN IN A CLINICAL SETTING - THE 1ST 100 CONSECUTIVE PATIENTS WITH ACUTE MIGRAINE IN A TERTIARY CARE CENTER
Authors: SHEFTELL FD WEEKS RE RAPOPORT AM SIEGEL S BASKIN S ARROWSMITH F
Citation: Fd. Sheftell et al., SUBCUTANEOUS SUMATRIPTAN IN A CLINICAL SETTING - THE 1ST 100 CONSECUTIVE PATIENTS WITH ACUTE MIGRAINE IN A TERTIARY CARE CENTER, Headache, 34(2), 1994, pp. 67-72
Risultati: 1-18 |